A federal appeals court ruled that President Donald Trump's stated policy goal of ending gender-affirming care does not provide grounds for quashing a subpoena directed at a healthcare provider, according to a decision released this week.
The three-judge panel from a federal appellate court rejected arguments that Trump's political opposition to gender transition treatments constitutes an improper basis for a legal demand. The court found that subpoenas can proceed even when they target healthcare providers treating patients for gender dysphoria, as long as the legal demand itself follows proper procedural rules.
Trump has made ending gender-affirming medical care a centerpiece of his second-term agenda. His administration has promised to strip federal funding from hospitals and clinics providing puberty blockers, hormone therapy, and surgical interventions for transgender patients. The Department of Health and Human Services has signaled its intent to reclassify these treatments as experimental procedures lacking sufficient evidence.
The subpoena in question targeted a provider of gender-affirming care in connection with ongoing litigation. Defense attorneys argued that the subpoena represented retaliation against the provider for offering treatments Trump opposes. They claimed that allowing such a subpoena would chill healthcare providers' willingness to offer these services and violate First Amendment protections.
The appeals court disagreed. Judges ruled that a party's personal or political opposition to a category of medical treatment does not automatically invalidate a subpoena. The court emphasized that subpoenas remain valid tools for obtaining evidence in legal proceedings, regardless of the political positions held by those seeking the evidence.
The decision carries implications for the administration's broader push against gender-affirming care. It suggests that courts will not readily accept arguments that Trump's policies targeting these treatments amount to pretextual harassment of providers. Medical organizations and civil rights advocates had warned that such subpoenas could discourage doctors from offering legally protected care.
Trump's position on transgender medical care aligns with broader Republican efforts to restrict access. During his first term, he attempted to ban transgender individuals from military service. His current administration has signaled intent to challenge state laws that protect healthcare providers offering gender-affirming treatments and to pursue federal restrictions through executive action and legislative measures.
The legal fight over subpoenas reflects a collision between Trump's executive authority to pursue policy goals and claims that such pursuits can weaponize legal mechanisms. Healthcare providers face growing pressure as multiple states have enacted laws banning gender-affirming care for minors, while some states have moved to protect these treatments.
This appeals court ruling does not address the underlying constitutional questions about whether the government can ban gender-affirming care entirely. Instead, it addresses the narrower procedural question of whether a subpoena remains enforceable when issued by parties opposing such care.
The case may proceed to higher courts if the healthcare provider seeks further appeal. The ruling establishes that Trump's policy agenda, however controversial, does not by itself invalidate legal discovery requests in civil or criminal proceedings.